Robert Panton requested funding for the pilot study. Read more about Robert Panton requested funding for the pilot study.
Professor John Cash asked Dr Ginger Rosenberg at Chiron for access in due course to antibody testing kits for evaluation purposes. Read more about Professor John Cash asked Dr Ginger Rosenberg at Chiron for access in due course to antibody testing kits for evaluation purposes.
The "line to take" included "UK blood is still considered one of the safest in the world, and we continue to investigate ways of making it safer still" and "The prevalence of Hepatitis C in the population in this country has not been established, nor has the role of blood in its transmission." Read more about The "line to take" included "UK blood is still considered one of the safest in the world, and we continue to investigate ways of making it safer still" and "The prevalence of Hepatitis C in the population in this country has not been established, nor has the role of blood in its transmission."
In the mid to late 1980s in the US, the incidence of non-A non-B Hepatitis was 7-12%. Read more about In the mid to late 1980s in the US, the incidence of non-A non-B Hepatitis was 7-12%.
Anti-HCV testing was to begin on 1 September 1991. Read more about Anti-HCV testing was to begin on 1 September 1991.
The full report for the multi-centre study on non-A non-B Hepatitis surrogate screening was eventually completed in April 1990. Read more about The full report for the multi-centre study on non-A non-B Hepatitis surrogate screening was eventually completed in April 1990.
Dr Lloyd wrote to Professor Cash reiterating his concern that the UK was "dragging its feet over testing" and was running the risk of "accepting the lowest common denominator" approach. Read more about Dr Lloyd wrote to Professor Cash reiterating his concern that the UK was "dragging its feet over testing" and was running the risk of "accepting the lowest common denominator" approach.
Brown and Thomas published "Blood Transfusion Services Should Have Begun Screening for Hepatitis C When an Antibody Assay First Became Available" in "Reviews in Medical Virology". Read more about Brown and Thomas published "Blood Transfusion Services Should Have Begun Screening for Hepatitis C When an Antibody Assay First Became Available" in "Reviews in Medical Virology".
Dr Barbara went to the Paris meeting and regarded the test as "reproducible, robust and meaningful". Read more about Dr Barbara went to the Paris meeting and regarded the test as "reproducible, robust and meaningful".
"The Lancet" carried two letters on the topic of "Screening for Hepatitis C Virus Antibody", the first from Dr Contreras and Dr Barbara and the second from Professor Cash. Read more about "The Lancet" carried two letters on the topic of "Screening for Hepatitis C Virus Antibody", the first from Dr Contreras and Dr Barbara and the second from Professor Cash.